北大医药
(000788)
| 流通市值：32.06亿 | | | 总市值：32.06亿 |
| 流通股本：5.96亿 | | | 总股本：5.96亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 819,867,227.23 | 938,341,999.39 | 909,299,481.2 | 659,874,162.64 |
| 交易性金融资产 | 210,040,445.07 | 27,755,723.94 | - | 29,165,422.04 |
| 应收票据及应收账款 | 262,200,329.65 | 280,153,404.34 | 503,216,149.65 | 780,001,267.32 |
| 其中：应收票据 | 15,942,282.33 | 12,162,051 | 16,430,309.36 | 23,420,723.93 |
| 应收账款 | 246,258,047.32 | 267,991,353.34 | 486,785,840.29 | 756,580,543.39 |
| 应收款项融资 | 63,797,961.37 | 25,818,737.82 | 40,162,310.45 | 59,686,128.06 |
| 预付款项 | 8,475,026.8 | 18,113,764.37 | 9,768,402.24 | 14,592,122.83 |
| 其他应收款合计 | 47,072,351.32 | 60,604,738.45 | 59,947,706.74 | 64,337,013.03 |
| 存货 | 121,491,914.33 | 115,497,387.34 | 134,606,178.08 | 144,050,213.88 |
| 其他流动资产 | 10,900,352.24 | 9,597,207.4 | 5,474,639.24 | 4,472,847.94 |
| 流动资产合计 | 1,543,845,608.01 | 1,475,882,963.05 | 1,662,474,867.6 | 1,756,179,177.74 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 22,022,300 | 22,022,300 | - | - |
| 投资性房地产 | 26,009,205.5 | 14,049,740.35 | 14,376,478.51 | 14,703,216.67 |
| 固定资产 | 104,994,134.99 | 117,466,082.17 | 122,596,786.23 | 118,074,054.76 |
| 在建工程 | - | 3,906,264.61 | 2,262,016.82 | 162,131.86 |
| 使用权资产 | 88,729,190.18 | 93,705,374.3 | 17,016,815.13 | 20,148,932.88 |
| 无形资产 | 83,844,897.72 | 93,680,627.04 | 90,165,882.99 | 124,460,077.59 |
| 开发支出 | 6,829,669.97 | 14,678,701.42 | 19,878,780.76 | 20,571,442.52 |
| 长期待摊费用 | 319,830.48 | 338,644.05 | 357,457.62 | - |
| 递延所得税资产 | 9,613,715.59 | 8,737,320.71 | 17,246,110.37 | 7,115,391.65 |
| 其他非流动资产 | 36,687,070.72 | 41,293,915.73 | 46,440,689.43 | 37,475,536.45 |
| 非流动资产合计 | 379,050,015.15 | 409,878,970.38 | 330,341,017.86 | 342,710,784.38 |
| 资产总计 | 1,922,895,623.16 | 1,885,761,933.43 | 1,992,815,885.46 | 2,098,889,962.12 |
| 流动负债: | | | | |
| 短期借款 | 5,118,625.93 | 3,435,981.26 | 5,942,460.44 | 30,025,833.31 |
| 应付票据及应付账款 | 161,410,976.27 | 157,006,895.65 | 192,167,443.44 | 272,452,502.32 |
| 其中：应付票据 | 42,152,117.38 | 42,088,777.54 | 49,574,604.84 | 70,274,408.5 |
| 应付账款 | 119,258,858.89 | 114,918,118.11 | 142,592,838.6 | 202,178,093.82 |
| 合同负债 | 6,667,872.76 | 8,825,233.26 | 9,793,163.35 | 4,843,373.48 |
| 应付职工薪酬 | 28,057,027.2 | 24,207,535.77 | 46,620,579.27 | 23,276,283.74 |
| 应交税费 | 7,428,250.77 | 3,559,640.47 | 3,589,178.67 | 12,653,625.28 |
| 其他应付款合计 | 95,568,677.25 | 95,697,113.33 | 95,633,490.57 | 105,710,483.57 |
| 应付股利 | - | - | - | 6,084,284.99 |
| 一年内到期的非流动负债 | 19,651,802.85 | 19,659,574.57 | 13,620,196.83 | 13,277,888.19 |
| 其他流动负债 | 868,540.51 | 1,150,081.16 | 1,268,663.62 | 627,938.57 |
| 流动负债合计 | 324,771,773.54 | 313,542,055.47 | 368,635,176.19 | 462,867,928.46 |
| 非流动负债: | | | | |
| 租赁负债 | 64,170,972.33 | 66,082,739.11 | 3,544,743.38 | 4,860,776.12 |
| 预计负债 | 1,695,298.32 | 2,319,688.48 | 43,113,418.75 | - |
| 递延收益 | 15,480,240.77 | 15,714,636.01 | 16,272,893.17 | 16,831,150.33 |
| 递延所得税负债 | - | - | 17,242.12 | - |
| 非流动负债合计 | 81,346,511.42 | 84,117,063.6 | 62,948,297.42 | 21,691,926.45 |
| 负债合计 | 406,118,284.96 | 397,659,119.07 | 431,583,473.61 | 484,559,854.91 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 595,987,425 | 595,987,425 | 595,987,425 | 595,987,425 |
| 资本公积 | 199,172,934.88 | 199,172,934.88 | 199,172,934.88 | 199,172,934.88 |
| 盈余公积 | 86,942,774.5 | 86,942,774.5 | 86,942,774.5 | 69,580,677.47 |
| 未分配利润 | 635,320,586.94 | 606,646,063.1 | 679,775,660.59 | 750,235,452.98 |
| 归属于母公司股东权益合计 | 1,517,423,721.32 | 1,488,749,197.48 | 1,561,878,794.97 | 1,614,976,490.33 |
| 少数股东权益 | -646,383.12 | -646,383.12 | -646,383.12 | -646,383.12 |
| 股东权益合计 | 1,516,777,338.2 | 1,488,102,814.36 | 1,561,232,411.85 | 1,614,330,107.21 |
| 负债和股东权益合计 | 1,922,895,623.16 | 1,885,761,933.43 | 1,992,815,885.46 | 2,098,889,962.12 |
| 公告日期 | 2026-08-25 | 2026-04-28 | 2026-04-28 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |